Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin
To compare the efficacy, safety, and cost of prophylactic low-dose ganciclovir with that of immunoglobulin in renal transplant recipients at risk for primary cytomegalovirus (CMV) disease. A prospective, randomized trial at a 650-bed tertiary medical center hospital. Fifty-one consecutive CMV-serone...
Saved in:
Published in | Archives of surgery (Chicago. 1960) Vol. 129; no. 4; p. 443 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.04.1994
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | To compare the efficacy, safety, and cost of prophylactic low-dose ganciclovir with that of immunoglobulin in renal transplant recipients at risk for primary cytomegalovirus (CMV) disease.
A prospective, randomized trial at a 650-bed tertiary medical center hospital.
Fifty-one consecutive CMV-seronegative patients who received renal allografts from seropositive donors between March 1990 and April 1992.
Patient and allograft survival, and the incidence and severity of CMV disease.
Cytomegalovirus prophylaxis with seven doses of intravenous immunoglobulin for 6-week periods (group 1, n = 27) or low-dose intravenous ganciclovir for 3 weeks (group 2, n = 24). Results were compared with those obtained in 23 CMV-seronegative historical controls who received renal allografts from CMV-seropositive donors between 1987 and 1989, and who did not receive prophylaxis for CMV (group 3).
Both prophylactic regimens significantly reduced the incidence of invasive CMV infection (P < .05) and were well tolerated. However, the cost of ganciclovir ($350 per patient) was substantially less than that of immunoglobulin ($4000 per patient).
These data suggest that prophylactic ganciclovir therapy provides a cost-effective approach toward significantly improving the outcome of renal transplantation in recipients at risk for primary CMV disease. |
---|---|
AbstractList | To compare the efficacy, safety, and cost of prophylactic low-dose ganciclovir with that of immunoglobulin in renal transplant recipients at risk for primary cytomegalovirus (CMV) disease.
A prospective, randomized trial at a 650-bed tertiary medical center hospital.
Fifty-one consecutive CMV-seronegative patients who received renal allografts from seropositive donors between March 1990 and April 1992.
Patient and allograft survival, and the incidence and severity of CMV disease.
Cytomegalovirus prophylaxis with seven doses of intravenous immunoglobulin for 6-week periods (group 1, n = 27) or low-dose intravenous ganciclovir for 3 weeks (group 2, n = 24). Results were compared with those obtained in 23 CMV-seronegative historical controls who received renal allografts from CMV-seropositive donors between 1987 and 1989, and who did not receive prophylaxis for CMV (group 3).
Both prophylactic regimens significantly reduced the incidence of invasive CMV infection (P < .05) and were well tolerated. However, the cost of ganciclovir ($350 per patient) was substantially less than that of immunoglobulin ($4000 per patient).
These data suggest that prophylactic ganciclovir therapy provides a cost-effective approach toward significantly improving the outcome of renal transplantation in recipients at risk for primary CMV disease. |
Author | Freed, B M Conti, D J Lempert, N Gruber, S A |
Author_xml | – sequence: 1 givenname: D J surname: Conti fullname: Conti, D J organization: Department of Surgery, Albany Medical College, NY – sequence: 2 givenname: B M surname: Freed fullname: Freed, B M – sequence: 3 givenname: S A surname: Gruber fullname: Gruber, S A – sequence: 4 givenname: N surname: Lempert fullname: Lempert, N |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8154971$$D View this record in MEDLINE/PubMed |
BookMark | eNotkD1vwyAYhBlSpUnan1CJoatdwGCbMYr6JUVqh3aOAGOHCoMFdlr_-6LW03t67_RId1uwct5pAO4xyjFC-EEEdY5T6HLMOc0RpgSRGmGCES5XYIMQolnKoWuwjfErKVJzsgbrGjPKK7wB3-_BD-fZih8ToW_hEEwvwgzVPPped8L6iwlThI2JWkQNjYNBO2HhGISLgxVuTA9lBqPdGHO4T4ZJdkJ1wimj_gDwEqHp-8n5zno5WeNuwFUrbNS3y92Bz6fHj8NLdnx7fj3sj5koimrMGsmYVk3NSkJVzaVAGjGaqre8rVRRVi1jJZMVZarhVCrBcKtJobVsSKkUJjtw988dJtnr5rT0Oy0DkF__VWTT |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1001/archsurg.1994.01420280121016 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | 8154971 |
Genre | Comparative Study Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -QF .55 .XZ 23N 2CT 2WC 354 39C 3O- 4.4 53G 5GY 6J9 AAWTL AAYEP ABCQX ABJNI ABOCM ACGFO ACGFS ADBBV AFFNX AI. ALMA_UNASSIGNED_HOLDINGS AMJDE ARBJA BRYMA C1A C45 CGR CS3 CUY CVF EAM EBS ECM EIF EJD EMOBN EX3 F5P GX1 IH2 J5H L7B N4W N9A NPM OB2 OBH OHH OVD P2P RAJ RWL RXW SJN SV3 TAE TEORI VH1 VVN WH7 WOW X6Y X7M XHN YOC ZE2 ZGI ZXP ZY1 |
ID | FETCH-LOGICAL-a337t-db55ecd85624c89ba0e054100f9f7c367f5565b745cd94bca51fe23eebd26cc12 |
ISSN | 0004-0010 |
IngestDate | Sat Sep 28 08:39:17 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a337t-db55ecd85624c89ba0e054100f9f7c367f5565b745cd94bca51fe23eebd26cc12 |
PMID | 8154971 |
ParticipantIDs | pubmed_primary_8154971 |
PublicationCentury | 1900 |
PublicationDate | 1994-04-01 |
PublicationDateYYYYMMDD | 1994-04-01 |
PublicationDate_xml | – month: 04 year: 1994 text: 1994-04-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Archives of surgery (Chicago. 1960) |
PublicationTitleAlternate | Arch Surg |
PublicationYear | 1994 |
SSID | ssj0012892 |
Score | 1.324548 |
Snippet | To compare the efficacy, safety, and cost of prophylactic low-dose ganciclovir with that of immunoglobulin in renal transplant recipients at risk for primary... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 443 |
SubjectTerms | Adult Cytomegalovirus Infections - prevention & control Drug Costs Female Follow-Up Studies Ganciclovir - economics Ganciclovir - therapeutic use Graft Rejection - etiology Graft Survival Humans Immunoglobulins, Intravenous - economics Immunoglobulins, Intravenous - therapeutic use Incidence Infusions, Intravenous Kidney Transplantation Length of Stay Male Prospective Studies Risk Factors Survival Rate |
Title | Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8154971 |
Volume | 129 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBbpxkZfRkdXtvWCHvoWHBJbtpzHrrQrYw19aKFvxbqNQBuHOMku_6f_c-foKLWWbWXdizESCEvn8-FcPzF2CEZxZvvVIFFSi0RI6ZJSDLPEWGQSsbZ0CuMd56Pi7Ep8us6vO537qGppMVc9_eOPfSX_I1UYA7lil-wTJPuwKAzAO8gXniBheP6TjC9mNZzSbfWNSEWmgTlCf5_XdxZUf70czxbNKglDrStUXY6M5rdwqF0kt5hiT2TTAx1Bd3jAUl-QhkP7BbrLpjvGLpIayUOwcD02aGPm2oZarH1imCo8el349fpRtAHJsKi1vc1Hnc4sRVw_tKHZj7OFCleCtdHWzxZsfGoxGrXRCqIdfihyWWlgGOiHUtaVBg6fMY7jC16fCuJw-k3P0_0CvnkHtoYtl6IHzl6KiWKkRKP-zQgC0zuPgRIZ6ejOl0cn1zi4w8wG25AlqtERhoRCqgo8VqKkDxt7yQ5X1FaPfd8mexFWXXNovGFzucVeBY-EHxG8XrOOnWyzrxG0eO14gBZfgxYP0OLjCffQ4i20eAQtfsQ9tHCpCFp82fBfofWGXZ2eXB6fJeGOjqTKMjlPjMpzq00JZrTQ5VBVfQtOAOzeDZ3UWSFdDi6DkiLXZiiUrvKBsykoAWXSQutBusOeTeqJfct4aqQBe7kotDNC5alSrsTEe-UGpTNZ9Y7t0DndhD3fhAN8_7eJXbbZYnCPPXfw39t9MCLn6sAL8SdVMXM3 |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prophylaxis+of+primary+cytomegalovirus+disease+in+renal+transplant+recipients.+A+trial+of+ganciclovir+vs+immunoglobulin&rft.jtitle=Archives+of+surgery+%28Chicago.+1960%29&rft.au=Conti%2C+D+J&rft.au=Freed%2C+B+M&rft.au=Gruber%2C+S+A&rft.au=Lempert%2C+N&rft.date=1994-04-01&rft.issn=0004-0010&rft.volume=129&rft.issue=4&rft.spage=443&rft_id=info:doi/10.1001%2Farchsurg.1994.01420280121016&rft_id=info%3Apmid%2F8154971&rft_id=info%3Apmid%2F8154971&rft.externalDocID=8154971 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-0010&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-0010&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-0010&client=summon |